Impracticalities of thiopurine S-methyltransferase determination in daily inflammatory bowel disease practice

Aliment Pharmacol Ther. 2006 Apr 15;23(8):1278-9; author reply 1279-80. doi: 10.1111/j.1365-2036.2006.02831.x.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cost-Benefit Analysis
  • Genotype
  • Humans
  • Inflammatory Bowel Diseases / therapy*
  • Methyltransferases / genetics*
  • Netherlands
  • Patient Selection*

Substances

  • Methyltransferases
  • thiopurine methyltransferase